Smith Asset Management Group »

Apellis Pharmaceuticals shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $5.0k 80 62.50
2021-03-31 $3.0k 80 37.50
2020-12-31 $148k 2.6k 57.36
2020-09-30 $78k 2.6k 30.12

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Apellis Pharmaceuticals

Wellington Management Company
EcoR1 Capital
venBio Select Advisor
Vanguard Group
BlackRock
Deep Track Capital
State Street Corporation
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
FMR
Jennison Associates
Siren
Geode Capital Management

View all funds holding Apellis Pharmaceuticals